placeUnited Kingdom
Contact & Support
Medtronic / Covidien Products / Vessel Sealing / BiZact™ Tonsillectomy Device / BiZact™ Tonsillectomy Made Better

You are entering HCP content only

Please note you are entering now content intended only for Healthcare Professionals.

Are you a HCP?

THE RIGHT TOOL MAKES ALL THE DIFFERENCE

BiZact™ has been built for one purpose and designed in collaboration with ENTs, to optimize tonsillectomies with clinically proven benefits for you and more importantly, your patients.

A DIFFERENT APPROACH TO TONSILLECTOMY

DISCOVER THE CLINICALLY PROVEN BENEFITS OF BIZACT™1,2,3,†

The BiZact™ device has been clinically shown to:

  • Reduce intraoperative blood loss1,††
  • Improve procedural efficiency1,4,5,‡

Results of a pilot study on Tonsillectomy using the BiZact™ device

DESIGNED SPECIFICALLY FOR TONSILLECTOMY

BIZACT™ TONSILLECTOMY DEVICE OPTIMIZES THE PROCEDURE FROM START TO FINISH

Surgeons using the BiZact™ device are completing cases in about half the time1,4,5,†† compared to the Coblator™* device and electrocautery.  Because the BiZact™ device: 

  • Offers a fast and easy setup6,₤
  • In‑line activation facilitates efficient sealing and transection
  • Reduces intraoperative bleeding1-3,§,Ω

LEARN FROM YOUR PEERS

Global Webinar Recording

Watch Now

PROCEDURAL VIDEOS AND GUIDES

Videos

5:10
watched
Tonsillectomy Procedure with BiZact™ device – Pf Von Lucken

Tips to help you optimize your technique

Download Now

Contact us for more information

Discover more about BiZact™ Device
  • † Used in 48 cases, including adults (22+) US (18+) EU the use of the BiZact™ tonsillectomy device resulted in non‑measurable bloodloss compared to published literature stating 10.83 ml for Coblator™*, 27.08 ml for electrocautery [Roje], and 125 ml [Lachanas] with cold knife.
  • †† Used in 48 cases, including adults (22+) US (18+) EU the use of the BiZact™ tonsillectomy device resulted in non‑measurable bloodloss.
  • ‡ Used in 48 cases, including adults (22+) US (18+) EU. Average procedure time for the BiZact™ tonsillectomy device was 7 min. compared to published literature stating 14.8 (pediatric) and 20.5 (adult) min. [Lee] for electrocautery and 27.3 min. [Omrani] for Coblator™*.
  • § Used in 48 cases, including adults (22+) US (18+) EU. The use of the BiZact™ tonsillectomy device resulted in non‑measurable blood loss compared to published literature stating 10.83 ml for Coblator™*, 27.08 ml for electrocautery [Roje], and 125 ml for cold knife [Lachanas].
  • ₤ 12 out of 12 surgeons and 13 out of 15 nurses surveyed agreed.
  • Ω Compared to electrocautery, Coblator™*, and cold knife.
  • 1. Karni, R., Attner, P. (2018). A prospective, multi‑center, single arm, non‑comparative pilot study of BiZact on adults undergoing tonsillectomy. Data on file. Study sponsored by Medtronic. ClinicalTrials.gov Identifier: NCT02876575
  • 2. Roje Z, Racić G, Dogas Z, Pisac VP, Timms M. Postoperative morbidity and histopathologic characteristics of tonsillar tissue following coblation tonsillectomy in children: a prospective randomized single‑blinded study. Coll Antropol. 2009;33(1):293–298.
  • 3. Lachanas VA, Prokopakis EP, Bourolias CA, et al. LigaSure™ versus cold knife tonsillectomy. Laryngoscope. 2005;115(9):1591–1594.
  • 4. Lee SW, Jeon SS, Lee JD, Lee JY, Kim SC, Koh YW. A comparison of postoperative pain and complications in tonsillectomy using BiClamp forceps and electrocautery tonsillectomy. Otolaryngol Head Neck Surg. 2008;139(2):228‑234.
  • 5. Omrani M, Barati B, Omidifar N, Okhovvat AR, Hashemi SA. Coblation™* versus traditional tonsillectomy: A double blind randomized controlled trial. J Res Med Sci. 2012;17(1):45‑50.
  • 6. Based on internal test report #RE00073873 and #RE00079704, Independent surgeon and nurse feedback collected during Medtronic sponsored labs. January and February 2017.
Corporate Resources
Medical Surgical Portfolio
Additional Resources
Contact Us
Medtronic Limited

Building 9, Croxley Park

Hatters Lane

Watford, WD18 8WW

United Kingdom

©2025 Medtronic